广州地区2021—2022年冬春季儿童蚂蚁螫伤85例临床分析  

Clinical Analysis of Ant Stings in 85 Cases of Children in Winter and Spring from 2021 to 2022 in Guangzhou

作　　者：李军[1] 李珮珊 LI Jun;LI Peishan(Department of Dermatology,Guangzhou Women and Children's Medical Center,Guangdong 510120,China)

机构地区：[1]广州市妇女儿童医疗中心皮肤科,广东广州510120

出　　处：《中国皮肤性病学杂志》2023年第10期1147-1150,共4页The Chinese Journal of Dermatovenereology

摘　　要：目的探讨广州地区冬春季儿童蚂蚁螫伤的临床特点,及其病程的影响因素。方法收集2021年12月—2022年3月至广州市妇女儿童医疗中心门诊就诊的85例蚂蚁螫伤儿童病例的临床资料,进行回顾性分析。结果85例病例临床症状主要表现为局部过敏反应,11例继发感染,4例伴荨麻疹等全身反应。采用对症治疗,85例均治愈,病程5~17 d。病程与螫伤皮疹数目及是否继发感染呈线性相关(P<0.05);病程与是否口服糖皮质激素及年龄、性别、气温、白细胞计数等均无明显相关(P>0.05)。结论亚热带地区冬春季仍有儿童蚂蚁螫伤发生的小高峰,其全身变态反应少见,继发感染并不少见,及时有效治疗预后良好。口服糖皮质激素对病程影响不大,病程延长与螫伤皮疹数目及继发感染关系更大。Objective To summarize the clinical characteristics of ant stings in children in winter and spring in Guangzhou from 2021 to 2022 and explore factors affecting the disease course.Methods The clinical data of 85 cases of ant stings who visited the outpatient department of our hospital from December 2021 to March 2022 were collected and analyzed retrospectively.Results The clinical symptoms of 85 cases contained mainly local allergic reactions,including 11 cases with wound infections and 4 with systemic reactions such as urticaria.All 85 cases were cured by symptomatic treatment,and the disease duration was 5-17 days.The disease course was linearly correlated with the number of sting rashes and secondary infections,which was statistically significant(P<0.05).The disease duration was not significantly correlated with the use of oral corticosteroids,age,sex,air temperature,white blood cell count,etc(P>0.05).Conclusion Children may experience ant stings in subtropical regions in winter and spring.Systemic allergic reactions are rare,and secondary infections may occur.Timely and effective treatment yields a good prognosis.Oral corticosteroids have little effect on the course of the disease,and the prolongation of the disease is closely related to the number of sting rashes and secondary infections.

关 键 词：蚂蚁 螫伤 儿童 过敏反应 

分 类 号：R646[医药卫生—外科学]